We've found
12,214
archived clinical trials in
Women's Studies
We've found
12,214
archived clinical trials in
Women's Studies
Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Updated: 2/2/2016
A Multi-center Phase III Study Comparing Nonmyeloablative Conditioning With TBI Versus Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies
Status: Enrolling
Updated: 2/2/2016
Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Updated: 2/2/2016
A Multi-center Phase III Study Comparing Nonmyeloablative Conditioning With TBI Versus Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies
Status: Enrolling
Updated: 2/2/2016
Click here to add this to my saved trials

Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Updated: 2/2/2016
A Multi-center Phase III Study Comparing Nonmyeloablative Conditioning With TBI Versus Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies
Status: Enrolling
Updated: 2/2/2016
Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Updated: 2/2/2016
A Multi-center Phase III Study Comparing Nonmyeloablative Conditioning With TBI Versus Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies
Status: Enrolling
Updated: 2/2/2016
Click here to add this to my saved trials

Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Updated: 2/2/2016
A Multi-center Phase III Study Comparing Nonmyeloablative Conditioning With TBI Versus Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies
Status: Enrolling
Updated: 2/2/2016
Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Updated: 2/2/2016
A Multi-center Phase III Study Comparing Nonmyeloablative Conditioning With TBI Versus Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies
Status: Enrolling
Updated: 2/2/2016
Click here to add this to my saved trials

Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Updated: 2/2/2016
A Multi-center Phase III Study Comparing Nonmyeloablative Conditioning With TBI Versus Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies
Status: Enrolling
Updated: 2/2/2016
Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Updated: 2/2/2016
A Multi-center Phase III Study Comparing Nonmyeloablative Conditioning With TBI Versus Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies
Status: Enrolling
Updated: 2/2/2016
Click here to add this to my saved trials

Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Updated: 2/2/2016
A Multi-center Phase III Study Comparing Nonmyeloablative Conditioning With TBI Versus Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies
Status: Enrolling
Updated: 2/2/2016
Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Updated: 2/2/2016
A Multi-center Phase III Study Comparing Nonmyeloablative Conditioning With TBI Versus Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies
Status: Enrolling
Updated: 2/2/2016
Click here to add this to my saved trials

Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Updated: 2/2/2016
A Multi-center Phase III Study Comparing Nonmyeloablative Conditioning With TBI Versus Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies
Status: Enrolling
Updated: 2/2/2016
Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Updated: 2/2/2016
A Multi-center Phase III Study Comparing Nonmyeloablative Conditioning With TBI Versus Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies
Status: Enrolling
Updated: 2/2/2016
Click here to add this to my saved trials

Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Updated: 2/2/2016
A Multi-center Phase III Study Comparing Nonmyeloablative Conditioning With TBI Versus Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies
Status: Enrolling
Updated: 2/2/2016
Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Updated: 2/2/2016
A Multi-center Phase III Study Comparing Nonmyeloablative Conditioning With TBI Versus Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies
Status: Enrolling
Updated: 2/2/2016
Click here to add this to my saved trials

Effect of Psychological Intervention on Drop-out Rates in IVF
Updated: 2/3/2016
An Assessment of the Effect of a Brief Psychological Intervention on Decreasing Drop-Out Rates in IVF Patients
Status: Enrolling
Updated: 2/3/2016
Effect of Psychological Intervention on Drop-out Rates in IVF
Updated: 2/3/2016
An Assessment of the Effect of a Brief Psychological Intervention on Decreasing Drop-Out Rates in IVF Patients
Status: Enrolling
Updated: 2/3/2016
Click here to add this to my saved trials

Blood and Cerebrospinal Fluid for Pediatric Brain Tumor Research
Updated: 2/3/2016
Collection of Blood and Cerebrospinal Fluid for Pediatric Brain Tumor Research
Status: Enrolling
Updated: 2/3/2016
Blood and Cerebrospinal Fluid for Pediatric Brain Tumor Research
Updated: 2/3/2016
Collection of Blood and Cerebrospinal Fluid for Pediatric Brain Tumor Research
Status: Enrolling
Updated: 2/3/2016
Click here to add this to my saved trials

Ovarian Tissue Cryopreservation for Fertility Preservation
Updated: 2/3/2016
Ovarian Tissue Cryopreservation for Fertility Preservation
Status: Enrolling
Updated: 2/3/2016
Ovarian Tissue Cryopreservation for Fertility Preservation
Updated: 2/3/2016
Ovarian Tissue Cryopreservation for Fertility Preservation
Status: Enrolling
Updated: 2/3/2016
Click here to add this to my saved trials

Ovarian Tissue Cryopreservation for Fertility Preservation
Updated: 2/3/2016
Ovarian Tissue Cryopreservation for Fertility Preservation
Status: Enrolling
Updated: 2/3/2016
Ovarian Tissue Cryopreservation for Fertility Preservation
Updated: 2/3/2016
Ovarian Tissue Cryopreservation for Fertility Preservation
Status: Enrolling
Updated: 2/3/2016
Click here to add this to my saved trials

Study of the Validity of Using the MEQ to Measure Mindful Eating in Pregnant Women
Updated: 2/3/2016
Qualitative Evaluation of the Mindful Eating Questionnaire (MEQ) in Pregnant Women
Status: Enrolling
Updated: 2/3/2016
Study of the Validity of Using the MEQ to Measure Mindful Eating in Pregnant Women
Updated: 2/3/2016
Qualitative Evaluation of the Mindful Eating Questionnaire (MEQ) in Pregnant Women
Status: Enrolling
Updated: 2/3/2016
Click here to add this to my saved trials

Foley Catheter for Induction of Labor
Updated: 2/4/2016
A Randomized Control Trial of Foley Catheter Placement for Induction of Labor: Stylette Versus no Stylette
Status: Enrolling
Updated: 2/4/2016
Foley Catheter for Induction of Labor
Updated: 2/4/2016
A Randomized Control Trial of Foley Catheter Placement for Induction of Labor: Stylette Versus no Stylette
Status: Enrolling
Updated: 2/4/2016
Click here to add this to my saved trials

Comparing Outcomes of Elbow Extension Tendon Transfers
Updated: 2/8/2016
A Comparison of Two Surgical Procedures That Restore Elbow Extension
Status: Enrolling
Updated: 2/8/2016
Comparing Outcomes of Elbow Extension Tendon Transfers
Updated: 2/8/2016
A Comparison of Two Surgical Procedures That Restore Elbow Extension
Status: Enrolling
Updated: 2/8/2016
Click here to add this to my saved trials

Duloxetine for the Treatment of Postpartum Depression
Updated: 2/9/2016
Duloxetine in the Treatment of Postpartum-onset and Non-Postpartum Onset Major Depressive Disorder
Status: Enrolling
Updated: 2/9/2016
Duloxetine for the Treatment of Postpartum Depression
Updated: 2/9/2016
Duloxetine in the Treatment of Postpartum-onset and Non-Postpartum Onset Major Depressive Disorder
Status: Enrolling
Updated: 2/9/2016
Click here to add this to my saved trials

Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)
Updated: 2/9/2016
Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)
Status: Enrolling
Updated: 2/9/2016
Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)
Updated: 2/9/2016
Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)
Status: Enrolling
Updated: 2/9/2016
Click here to add this to my saved trials

DHA Supplementation and Pregnancy Outcome
Updated: 2/11/2016
Kansas University DHA Outcome Study (KUDOS)
Status: Enrolling
Updated: 2/11/2016
DHA Supplementation and Pregnancy Outcome
Updated: 2/11/2016
Kansas University DHA Outcome Study (KUDOS)
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials

DHA Supplementation and Pregnancy Outcome
Updated: 2/11/2016
Kansas University DHA Outcome Study (KUDOS)
Status: Enrolling
Updated: 2/11/2016
DHA Supplementation and Pregnancy Outcome
Updated: 2/11/2016
Kansas University DHA Outcome Study (KUDOS)
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials

The Copper T380A IUD vs. Oral Levonorgestrel for Emergency Contraception
Updated: 2/18/2016
Preventing Future Pregnancy After Choosing the Copper IUD vs. Oral Levonorgestrel for Emergency Contraception
Status: Enrolling
Updated: 2/18/2016
The Copper T380A IUD vs. Oral Levonorgestrel for Emergency Contraception
Updated: 2/18/2016
Preventing Future Pregnancy After Choosing the Copper IUD vs. Oral Levonorgestrel for Emergency Contraception
Status: Enrolling
Updated: 2/18/2016
Click here to add this to my saved trials

The Copper T380A IUD vs. Oral Levonorgestrel for Emergency Contraception
Updated: 2/18/2016
Preventing Future Pregnancy After Choosing the Copper IUD vs. Oral Levonorgestrel for Emergency Contraception
Status: Enrolling
Updated: 2/18/2016
The Copper T380A IUD vs. Oral Levonorgestrel for Emergency Contraception
Updated: 2/18/2016
Preventing Future Pregnancy After Choosing the Copper IUD vs. Oral Levonorgestrel for Emergency Contraception
Status: Enrolling
Updated: 2/18/2016
Click here to add this to my saved trials

Intrauterine Insemination In HIV-Discordant Couples
Updated: 2/19/2016
Intrauterine Insemination In HIV-Discordant Couples
Status: Enrolling
Updated: 2/19/2016
Intrauterine Insemination In HIV-Discordant Couples
Updated: 2/19/2016
Intrauterine Insemination In HIV-Discordant Couples
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Updated: 2/19/2016
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials

Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause
Status: Enrolling
Updated: 2/19/2016
Updated: 2/19/2016
Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause
Status: Enrolling
Updated: 2/19/2016
Updated: 2/19/2016
Click here to add this to my saved trials

Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause
Status: Enrolling
Updated: 2/19/2016
Updated: 2/19/2016
Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause
Status: Enrolling
Updated: 2/19/2016
Updated: 2/19/2016
Click here to add this to my saved trials

Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause
Status: Enrolling
Updated: 2/19/2016
Updated: 2/19/2016
Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause
Status: Enrolling
Updated: 2/19/2016
Updated: 2/19/2016
Click here to add this to my saved trials
